1-7 of 7
Christopher Yasenchak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Analysis of Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Nonbulky, Early-Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Eva Domingo Domenech, Brian Hess, Steven Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Harsh R. Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Griffith Davis, Linda Ho, Christopher Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 460.
https://doi.org/10.1182/blood-2024-200992
Published: 2024
Journal Articles

Durability of Complete Responses in Patients from the ECHELON-3 Study

Christopher Yasenchak, Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Craig A. Portell, Francesco Zaja, Thorsten Zenz, Cecily Forsyth, Jin Seok Kim, Seok-Goo Cho, Jae-Yong Kwak, Hao-Yuan Wang, Herve Ghesquieres, Grzegorz S. Nowakowski, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Frank Stenner
Journal: Blood
Blood (2024) 144 (Supplement 1): 3101.
https://doi.org/10.1182/blood-2024-194158
Published: 2024
Journal Articles

Optec: A Phase 2 Study to Evaluate Outpatient Step-up Administration of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results

Robert Rifkin, Henning Schade, Gary Simmons, Christopher Yasenchak, Jessica Fowler, Thomas S. Lin, Lijuan Kang, Weiming Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4753.
https://doi.org/10.1182/blood-2024-207295
Published: 2024
Journal Articles

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Uwe Hahn, Nancy L. Bartlett, Jeong-A Kim, Krimo Bouabdallah, Nicholas Forward, Tsai-Yun Chen, Vincent Camus, Ming-Chung Wang, Philippe Carassou, Enrico Derenzini, Hung Chang, Fritz Offner, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Craig A. Portell
Journal: Blood
Blood (2024) 144 (Supplement 1): 4489.
https://doi.org/10.1182/blood-2024-200914
Published: 2024
Journal Articles

Outcomes in Older Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Isabelle Fleury, Kamel Laribi, Juan Miguel Bergua Burgues, Craig A. Portell, Melina Boutin, Blanca Sanchez Gonzalez, Selay Lam, Sung Yong Oh, Judit Mészáros Joergensen, Young Rok Do, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Vincent Ribrag
Journal: Blood
Blood (2024) 144 (Supplement 1): 4483.
https://doi.org/10.1182/blood-2024-200836
Published: 2024
Journal Articles

Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)

Christopher Yasenchak, Rodolfo Bordoni, Dipti Patel-Donnelly, Timothy Larson, Jerome Goldschmidt, Ralph Boccia, Vivian J. M. Cline, Shweta Jain, Jingmin Liu, Joseph Thaddeus Beck
Journal: Blood
Blood (2023) 142 (Supplement 1): 4435.
https://doi.org/10.1182/blood-2023-190260
Published: 2023
Journal Articles

Response to Rituximab in Type II Cryoglobulinemia.

Alan H. Bryce, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Martha Lacy, MD, S. Vincent Rajkumar, MD, David James Inwards, MD, Christopher Yasenchak, MD, Shaji Kumar, MD, Morie Abraham Gertz, MD
Journal: Blood
Blood (2005) 106 (11): 3499.
https://doi.org/10.1182/blood.V106.11.3499.3499
Published: 2005